Skip to content
Search
Please enter at least 3 characters.

Latest Stories

‘Large quantity’ of prescription-only medication stolen from West Derby pharmacy

‘Large quantity’ of prescription-only medication stolen from West Derby pharmacy

The stolen medication includes diazepam, codeine, co-codamol, pregabalin, zopiclone, which could cause “serious harm” if a significant amount is taken

Merseyside Police have appealed for information from the public following the theft of “a large quantity” of medication from a pharmacy in West Derby this week.


As per the police report, the burglary occurred in the early hours of Monday, 12 February, at the pharmacy situated on Deysbrook Lane. Authorities were informed at around 9:15 am.

Based on the CCTV footage they have recovered, the Merseyside Police revealed that a man entered the pharmacy at around 1.20 am on 12 February and stole a large quantity of medication, including diazepam, codeine, co-codamol, pregabalin, zopiclone.

These are prescription-only drugs that could cause “serious harm” if a significant amount is taken, the report said.

The suspect, described as a white man of slim build, was wearing a grey coloured tracksuit and glasses, according to the police.

Detective Inspector Michael Fletcher has urged individuals possessing any information to come forward and assist in finding the stolen medication and identifying the perpetrator.

“Taking any medication which has not been prescribed for you can be dangerous and, in some circumstances, can prove fatal so I am urging residents or members of the public to please be cautious if you have seen the stolen tablets.

“If you come across them, please do not take them. Instead, call us immediately. Our enquiries into the burglary are ongoing so if you know this man, have seen the medication, or have any information, please contact us,” the inspector said.

The police have asked anyone with information about the medication to hand it in to any pharmacy or police station immediately and call officers on 101, or Crimestoppers anonymously on 0800 555 111 using reference 24000166676.

More For You

Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
PHOENIX expands operations with new depot in Aberdeen

Representational image

Photo credit: PHOENIX

PHOENIX opens new depot in Aberdeen

PHOENIX has announced the opening of a new depot in Aberdeen to support its growing customer base in Scotland.

The pharmaceutical wholesaler already operates 13 depots across the UK, collectively delivering over 250 million packs of medicines each year.

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Trump signs executive order to accelerate US-based pharmaceutical manufacturing plants

US president Donald Trump

Pic credit: Getty Images

Trump signs executive order to encourage US drug manufacturing

US president Donald Trump signed an executive order on Monday that aims to reduce the time it takes to approve pharmaceutical plants in the country, as part of new regulations to encourage domestic manufacturing.

The order directs the US Food and Drug Administration to streamline reviews and work with domestic manufacturers to provide early support before facilities come online.

Keep ReadingShow less